| |
Saturday July 2 nd, 2005 |
| |
|
| 09.00-09.45 |
Registration |
| |
|
| 09.45-10.00 |
Opening remarks
Filippo Drago (Catania) |
| |
|
| 10.00-11.00 |
Opening lecture (introduced by Filippo Drago) |
| |
Interaction between 5-HT3 receptors and cannabinoids: basic evidence, functional and putative therapeutic implications |
| |
Manfred Göthert (Bonn) |
|
|
| |
|
| 11.00-11.30 |
Welcome reception |
| |
|
Neurodegenerative diseases: general and common features |
| |
|
| Chairman: |
Pier Luigi Canonico (Novara) |
| |
|
| 16.00-17.00 |
Genetics of neurodegenerative diseases |
| |
Mario Zappia (Catania) |
| |
|
| 17.00-18.00 |
Biochemical basis of neurodegeneration |
| |
Daniele F. Condorelli (Catania) |
| |
|
| 18.00-18.30 |
Discussion |
| |
|
| 18.30-19.30 |
Lectura |
| |
Impaired DNA repair systems and neurodegenerative diseases |
| |
Maurizio Memo (Brescia) |
| |
|
| 19:30-19:40 |
Questionnaire |
| |
|
| |
|
| |
|
| |
Sunday July 3 rd, 2005 |
| |
|
Alzheimer disease: molecular biology |
| |
|
| Chairman: |
Giancarlo Pepeu (Florence) |
| |
|
| 10.00-11.00 |
Pharmacogenomics of AD |
| |
Sebastiano Cavallaro(Catania) |
| |
|
| 11.00-12.00 |
Apoptosis and neurogenesis in AD |
| |
Agata Copani (Catania) |
| |
|
| 12.00-12.30 |
Discussion |
| |
|
| Chairman: |
Stefano Govoni (Pavia) |
| |
|
| 16.00-17.00 |
Has the cholinergic deficit still a key role in AD? |
| |
Giancarlo Pepeu (Florence) |
| |
|
| 17.00-18.00 |
Neurotransmitter alteration in AD and new therapeutic options |
| |
Ezio Giacobini (Geneva) |
| |
|
| 18.00-18.30 |
Discussion |
| |
|
| 18:30-18:40 |
Questionnaire |
| |
|
| |
|
| |
|
| |
Monday July 4 th, 2005 |
| |
|
Alzheimer disease: clinics and therapeutics |
| |
|
| Chairman: |
Ezio Giacobini (Geneva) |
| |
|
| 10.00-11.00 |
The taupathies |
| |
Maria Grazia Spillantini (Cambridge) |
| |
|
| 11.00-12.00 |
Not only amnesia |
| |
Eugenio Aguglia (Trieste) |
| |
|
| 12.00-12.30 |
Discussion |
| |
|
| Chairman: |
Giancarlo Pepeu (Florence) |
| |
|
| 16.00-17.00 |
New therapeutic options in AD |
| |
Stefano Govoni (Pavia) |
| |
|
| 17.00-18.00 |
Pharmacological interactions in the treatment of AD |
| |
Riccardo Torta (Turin) |
| |
|
| 18.00-18.30 |
Discussion |
| |
|
| 18.30-19.30 |
Lectura |
| |
Off label use of antipsychotics |
| |
Stuart A. Montgomery (London) |
| |
|
| 19:30-19:40 |
Questionnaire |
| |
|
| |
|
| |
|
| |
Tuesday July 5 th, 2005 |
| |
|
Parkinson disease: molecular biology |
| |
|
| Chairman: |
Maria Angela Sortino (Catania) |
| |
|
| 10.00-11.00 |
Dopamine and central circuitry |
| |
Micaela Morelli (Cagliari) |
| |
|
| 11.00-12.00 |
Environmental factors and neurotoxicity in PD |
| |
Roberto Maggio (Pisa) |
| |
|
| 12.00-12.30 |
Discussion |
| |
|
| Chairman: |
Eugenio Aguglia (Trieste) |
| |
|
| 16.00-17.00 |
Excitatory synaptic organization in neurodegenerative diseases |
| |
Monica Di Luca (Milan) |
| |
|
| 17.00-18.00 |
Basic mechanisms of striatal synaptic plasticity |
| |
Antonio Pisani (Rome) |
| |
|
| 18.00-18.30 |
Discussion |
| |
|
| 18.30-19.30 |
Lectura |
| |
Genetic basis of PD |
| |
Olaf Riess (Tübingen) |
| |
|
| 19.30-19.40 |
Questionnaire |
| |
|
| |
|
| |
|
| |
Wednesday July 6th, 2005 |
| |
|
Parkinson disease: clinics and therapeutics |
| |
|
| Chairman: |
Antonio Pisani (Rome) |
| |
|
| 10.00-11.00 |
Clinical aspects of PD |
| |
Thomas Klockgether (Bonn) |
| |
|
| 11.00-12.00 |
Psychiatric aspects of PD |
| |
Donatella Marazziti (Pisa) |
| |
|
| 12.00-13.00 |
Special lecture (sponsored by Eli Lilly) |
| |
Depression in PD |
| |
Mario Zappia (Catania) |
| |
|
| 13.00-13:30 |
Discussion |
| |
|
| Chairman: |
Marco Onofrj (Chieti) |
| |
|
| 16.00-17.00 |
New horizons in the treatment of PD |
| |
Paolo Del Dotto (Pisa) |
| |
|
| 17.00-18.00 |
Advanced phase of PD: treatment of motor complications and psychosis |
| |
Letterio Morgante (Messina) |
| |
|
| 18.00-18.30 |
Discussion |
| |
|
| 18.30-19.30 |
Lectura |
| |
Diagnosis and treatment of dementia associated with PD |
| |
Marco Onofrj (Chieti) |
| |
|
| 19:30-19:40 |
Questionnaire |
| |
|
| |
|
| |
|
| |
Thursday July 7 th, 2005 |
| |
|
Multiple sclerosis |
| |
|
| Chairman: |
Arturo Reggio (Catania) |
| |
|
| 10.00-11.00 |
Genetics of demielinizating diseases |
| |
Luigi Grimaldi (Cefalù) |
| |
|
| 11.00-12.00 |
Tissue damage and clinical outcome |
| |
Carlo Pozzilli (Rome) |
| |
|
| 12.00-12.30 |
Discussion |
| |
|
| Chairman: |
Carlo Pozzilli (Rome) |
| |
|
| 16.00-17.00 |
Neurologic and psychiatric profile of MS |
| |
Arturo Reggio (Catania) |
| |
|
| 17.00-18.00 |
Present and future therapeutic options in MS |
| |
Giovanni Savettieri (Palermo) |
| |
|
| 18.00-18.30 |
Discussion |
| |
|
| 18.30-19.30 |
Lectura |
| |
Are lipid-lowering agents the neuroprotective drugs of the future? |
| |
Regis Bordet (Lille) |
| |
|
| 19:30-19:40 |
Questionnaire |
| |
|
| 21.00 |
Social Dinner |
| |
|
| |
|
| |
|
| |
Friday July 8 th, 2005 |
| |
|
Neuroinflammation |
| |
|
| Chairman: |
Renato Bernardini (Catania) |
| |
|
| 10.00-11.00 |
Proapoptotic cytokines in AD |
| |
Giuseppina Cantarella (Catania) |
| |
|
| 11.00-12.00 |
Immune response mediators and cells in amyotrophic lateral sclerosis |
| |
Tiziana Mennini (Milan) |
| |
|
| 12.00-12.30 |
Discussion |
|
|
| |
|
| 12.30-12.45 |
Closing remarks |
| |
Filippo Drago (Catania) |
| |
|
| 12:45-12:55 |
Questionnaire |
